Search Results 2461-2470 of 17655 for rheumatoid arthritis

1. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Has received treatment with 1 or more tumour necrosis factor (TNF) antagonists or vedolizumab at a dose approved for the treatment of UC, and has a ...

2. Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer - Mayo Clinic

   Prior therapy with monoclonal antibodies or small molecule inhibitors against Vascular endothelial growth factor (VEGF) or VEGF receptors, including Avastin® or ...

3. Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism - Mayo Clinic

   Subjects who within 48 hours of randomization have used an anti-Factor IIa agent such as dabigatran or an anti-FXa agent such as rivaroxaban, apixaban, or ...

4. A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer - Mayo Clinic

   Patients with tumors tested positive for epidermal growth factor receptor (EGFR) gene mutations, anaplastic lymphoma kinase (ALK) gene translocations, or C-ros ...

5. Glossary - Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery - Mayo Clinic Research

   Chronic diseases, such as diabetes, heart disease and arthritis, that persist over time and require consistent efforts to keep the disease from progressing or ...

6. Bone cancer - Doctors and departments - Mayo Clinic

   ... arthritis, Knee arthritis, Soft tissue sarcoma, Sarcoma, Bone metastasis, Failed total hip replacement, Failed total knee replacement, Pelvic bone tumor ...

7. Raynaud's disease - Doctors and departments - Mayo Clinic

   Departments that treat this condition · Cardiovascular Medicine · Cardiovascular Surgery · Rheumatology · Scleroderma Clinic · Vascular centers ...

8. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

   ... Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite the use of ...

9. Publications - Robert J. Witte, M.D. - Mayo Clinic

   Arthritis Rheum. 1999 Oct; 42(10):2243-8. View PubMed; Witte RJ. Imaging advances in oncology. Cancer Research, Therapy & Control. 1999; 9(3-4):389-93. Witte ...

10. Aspiring to deliver new cures for complex conditions - Mayo Clinic News Network

    ... rheumatology and dermatology. Research teams will work with partners in the practice to investigate the immunology of cells and autoimmune and inflammatory ...